Jon Weston, MBA
President & CEO
30 years in biopharmaceuticals and medical devices; Leadership roles to develop and launch Arthrotec & Celebrex ($4B sales), medical devices for transfusion, GI & cardiac care (>$1B sales)
Ray Goodrich, PhD
29 years in transfusion medicine & hematology; Founded 2 startups generating >$1B in value; Led R&D organization generating >$1B in sales; Awarded 58 patents; Coauthored >200 papers
Amanda Guth, DVM, PhD
Chief Science Officer
20 years immuno-oncology experience; Multiple patent holder; Developed immune assays and therapies for humans and animals; Authored > 20 papers
Gary Gordon, MD, PHD
Former Vice President, Oncology Department at Abbvie; 23 years oncology drug development; 14 years Professor of Oncology, Johns Hopkins Hospital.
Alan Rudolph, PhD, MBA
VP for Research, CSU; 20 years leadership at Naval Research Laboratory and DARPA; 15 years C-level Biotech roles.
Terry Opgenorth, PhD
VP, CSU Ventures; 20 years at Abbott drug development, 10 years Biotech C-level leadership roles